Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOX

BACKGROUND: High serum uric acid (SUA) levels increase the risk of overall cancer morbidity and mortality, particularly for digestive malignancies. Nevertheless, the correlation between SUA level and clinical outcomes of the postoperative patients with colorectal cancer (CRC) treated by chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Chen, Qing-hong, Yang, Ying, Lin, Jing-xin, Li, Yan-chun, Zhong, Tian-yu, Chen, Jie, Wu, Si-qi, Chen, Xiao-hu, Zhou, Rui-si, Lin, Jia-man, Wang, Dong-qing, He, Qiu-xing, You, Yan-ting, Zhou, Xing-hong, Zuo, Qiang, Liu, Yan-yan, Cheng, Jing-ru, Wu, Yi-fen, Zhao, Xiao-shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369254/
https://www.ncbi.nlm.nih.gov/pubmed/35965512
http://dx.doi.org/10.3389/fonc.2022.918088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369254/
https://www.ncbi.nlm.nih.gov/pubmed/35965512
http://dx.doi.org/10.3389/fonc.2022.918088

Ejemplares similares